BLOOMBERG: Ebola Vaccine: GlaxoSmithKline Trial Found Safe

  

GlaxoSmithKline completed an initial step toward making an Ebola vaccine widely available after a study with 20 healthy adults produced responses from the immune system and didn’t raise safety concerns. Bloomberg Intelligence’s Sam Fazeli discusses the impact of the study with Anna Edwards on “Countdown.”